 Defective oral tolerance promotes experimental IgA nephropathy oral immunization Oral tolerance important feature mucosal immune system immune-mediated disease production systemic IgG IgM antibody immunogens present mucosal surfaces study role oral tolerance mucosal immunoregulation experimental model IgA IgAN important form nephritis humans Cyclophosphamide estradiol expression oral tolerance chronic oral presentation Ag BALB/c mice drinking water bovine gamma globulin BGG wk groups mg cyclophosphamide mg estradiol drugs Groups control mice BGG drugs separate experiments low percentage saline-treated immunized mice hematuria nonimmunized controls mice estradiol and/or cyclophosphamide appropriate times significant hematuria drugs suboptimal times mice hematuria Drug-treated immunized mice serum IgG IgM anti-BGG antibodies control saline groups Immunofluorescence glomerular deposits IgG IgM drug-treated immunized mice saline-treated immunized normal untreated control mice Hematuria glomerular deposits IgG IgM serum IgG IgM antibody immunized mice significant mesangial IgA BGG deposits differences deposits saline- drug-treated immunized mice blunting oral tolerance promotion systemic IgG IgM antibody production immunized mice glomerular immune complexes IgG and/or IgM promote complement deposition hematuria IgAN Analogous defects oral mucosal tolerance role genesis symptomatic human IgAN